SCYNEXIS Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 7.37M and sold 30.36K SCYX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
100.00
Buy 7.37M shares
Sell 30.36K shares
98% Buy Activity
Weak Negative Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Jun 26, 2025
Buy
Common Stock
A-Award
Hastings David C
Director
Director 23 000
Value: $135.5K
Jun 26, 2025
Buy
Stock Option
A-Award
Macdonald Guy
Director
Director 23 000
Value: $17.0K
Jun 26, 2025
Buy
Common Stock
A-Award
Macdonald Guy
Director
Director 23 000
Value: $135.5K
Jun 26, 2025
Buy
Common Stock
A-Award
Tinmouth Brian Philippe
Director
Director 23 000
Value: $135.5K
Jun 26, 2025
Buy
Stock Option
A-Award
Tinmouth Brian Philippe
Director
Director 23 000
Value: $17.0K
Apr 09, 2025
Buy
Common Stock
A-Award
Angulo Gonzalez David
Chief Executive Officer
CEO / President 23 000
Value: $19.3K
Apr 09, 2025
Buy
Common Stock
A-Award
Angulo Gonzalez David
Chief Executive Officer
CEO / President 23 000
Value: $19.3K
Mar 20, 2025
Buy
Common Stock
A-Award
Angulo Gonzalez David
Chief Executive Officer
CEO / President 13 800
Value: $14.5K
Mar 20, 2025
Buy
Common Stock
A-Award
Angulo Gonzalez David
Chief Executive Officer
CEO / President 13 800
Value: $14.5K
Mar 19, 2025
Buy
Common Stock
A-Award
Angulo Gonzalez David
Chief Executive Officer
CEO / President 5 000
Value: $5K
Mar 19, 2025
Buy
Common Stock
A-Award
Angulo Gonzalez David
Chief Executive Officer
CEO / President 5 000
Value: $5K
Jan 23, 2025
Buy
Common Stock
A-Award
Sukenick Scott
Chief Legal Officer
Officer 92 511
Value: $799.3K
Jan 23, 2025
Buy
Employee Stock Option (Right to Buy)
A-Award
Sukenick Scott
Chief Legal Officer
Officer 138 767
Value: $149.9K
Jan 23, 2025
Buy
Common Stock
A-Award
Macleod Ivor
Chief Financial Officer
C-Suite Officer 92 511
Value: $799.3K
Jan 23, 2025
Buy
Employee Stock Option (Right to Buy)
A-Award
Macleod Ivor
Chief Financial Officer
C-Suite Officer 138 767
Value: $149.9K
Jan 23, 2025
Buy
Common Stock
A-Award
Angulo Gonzalez David
Chief Executive Officer
CEO / President 262 927
Value: $2.27M
Jan 23, 2025
Buy
Employee Stock Option (Right to Buy)
A-Award
Angulo Gonzalez David
Chief Executive Officer
CEO / President 394 391
Value: $425.9K
Jan 23, 2025
Buy
Employee Stock Option (Right to Buy)
A-Award
Angulo Gonzalez David
Chief Executive Officer
CEO / President 394 391
Value: $425.9K
Jan 23, 2025
Buy
Common Stock
A-Award
Angulo Gonzalez David
Chief Executive Officer
CEO / President 262 927
Value: $2.27M
Jan 23, 2025
Buy
Employee Stock Option (Right to Buy)
A-Award
Macleod Ivor
Chief Financial Officer
C-Suite Officer 138 767
Value: $149.9K
Jan 23, 2025
Buy
Common Stock
A-Award
Macleod Ivor
Chief Financial Officer
C-Suite Officer 92 511
Value: $799.3K
Jan 23, 2025
Buy
Employee Stock Option (Right to Buy)
A-Award
Sukenick Scott
Chief Legal Officer
Officer 138 767
Value: $149.9K
Jan 23, 2025
Buy
Common Stock
A-Award
Sukenick Scott
Chief Legal Officer
Officer 92 511
Value: $799.3K
Sep 12, 2024
Buy
Common Stock
P-Purchase
Angulo Gonzalez David
Chief Executive Officer
CEO / President 20 000
Value: $27.4K
Sep 12, 2024
Buy
Common Stock
P-Purchase
Angulo Gonzalez David
Chief Executive Officer
CEO / President 20 000
Value: $27.4K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT SCYNEXIS
SCYNEXIS
SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of various fungal infections, including recurrent VVC, invasive aspergillosis, invasive candidiasis, and refrac...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE